Evaluation of a New Noninvasive Glucose Monitoring Device by Means of Standardized Meal Experiments
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Frequent blood glucose readings are the most cumbersome aspect of diabetes treatment for many patients. The noninvasive TensorTip Combo Glucometer (CoG) component employs dedicated mathematical algorithms to analyze the collected signal and to predict tissue glucose at the fingertip. This study presents the performance of the CoG (the invasive and the noninvasive components) during a standardized meal experiment. Methods: Each of the 36 participants (18 females and males each, age: 49 ± 18 years, 14 healthy subjects, 6 type 1 and 16 type 2 patients) received a device for conducting calibration at home. Thereafter, they ingested a standardized meal. Blood glucose was assessed from capillary blood samples by means of the (non)invasive device, YSI Stat 2300 plus, Contour Next at time points –30, 0, 15, 30, 45, 60, 75, 90, 120, 150, and 180 minutes. Statistical analysis was performed by consensus error grid (CEG) and calculation of mean absolute relative difference (MARD) in comparison to YSI. Results: For the noninvasive (NI) CoG technology, 100% of the data pairs were found in CEG zones A (96.6%) and B (3.4%); 100% were seen in zone A for the invasive component and Contour Next. MARD was calculated to be 4.2% for Contour Next, 9.2% for the invasive component, and 14.4% for the NI component. Conclusions: After appropriate individual calibration of the NI technology, both the NI and the invasive CoG components reliably tracked tissue and blood glucose values, respectively. This may enable patients with diabetes to monitor their glucose levels frequently, reliably, and most of all pain-free.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
King, P., Peacock, I., & Donnelly, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00092.x · Cited by 695
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
Karter, A. J., Ackerson, L. M., Darbinian, J. A., D’Agostino, R. B., Ferrara, A., Liu, J., & Selby, J. V. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00742-2 · Cited by 595 · cited 1×
“It is therefore of particular importance to reduce the incidence of new diabetes manifestations by means of targeted prevention measures, and by employing measures to avoid disease progression until the development of diabetes complications.(2-4) One accepted measure is frequent glucose testing enabling targeted inter…”
BackgroundCurrent and Emerging Technology for Continuous Glucose Monitoring
Chen, C., Zhao, X.-L., Li, Z.-H., Zhu, Z.-G., Qian, S.-H., & Flewitt, A. (2017) · Sensors · doi:10.3390/s17010182 · Cited by 291 · cited 2×
“This fact explains why NI glucose monitoring methods are considered to be of limited efficacy in emergency situations.(14) However, the observed MARD of 14.”
BackgroundMartin, S., Schneider, B., Heinemann, L., Lodwig, V., Kurth, H.-J., Kolb, H., Scherbaum, W. A., & for the ROSSO Study Group (2006) · Diabetologia · doi:10.1007/s00125-005-0083-5 · Cited by 284
Schütt, M., Kern, Krause, U., Busch, Dapp, A., Grziwotz, Mayer, I., Rosenbauer, Wagner, C., Zimmermann, et al. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924152 · Cited by 218
Time Lag of Glucose From Intravascular to Interstitial Compartment in Type 1 Diabetes
Basu, A., Dube, S., Veettil, S., Slama, M., Kudva, Y. C., Peyser, T., Carter, R. E., Cobelli, C., & Basu, R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814554797 · Cited by 164 · cited 1×
“This lag time has been described to last from less than 10 minutes to more than 45 minutes based on the diabetes stage, and in particular also related to the severity of secondary microcirculation disorders.(25-27) This fact explains why NI glucose monitoring methods are considered to be of limited efficacy in emergen…”
BackgroundPredictors of control of diabetes: monitoring may be the key
Haller, M. J., Stalvey, M. S., & Silverstein, J. H. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.12.042 · Cited by 162 · cited 1×
“According to the United Kingdom Prospective Diabetes Study (UKPDS) and the Diabetes Control and Complications Trial (DCCT), frequent measurements help to reduce the incidence and progression of diabetes complications both in type 1 and type 2 diabetes,(2,15) have sustaining benefits regarding vascular disease outcomes…”
BackgroundDURÁN, A., MARTÍN, P., RUNKLE, I., PÉREZ, N., ABAD, R., FERNÁNDEZ, M., DEL VALLE, L., SANZ, M. F., & CALLE‐PASCUAL, A. L. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00081.x · Cited by 156 · cited 1×
“One accepted measure is frequent glucose testing enabling targeted intervention and treatment intensification at the appropriate time-points.(5-9) However, glucose measurement is the most cumbersome aspect of diabetes treatment for many patients and many of them fail to adhere to the corresponding recommendations over…”
BackgroundTechnical Aspects of the Parkes Error Grid
Pfützner, A., Klonoff, D. C., Pardo, S., & Parkes, J. L. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700517 · Cited by 122
Self-citationMollema, E. D., Snoek, F. J., Heine, R. J., & van der Ploeg, H. M. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00547.x · Cited by 110 · cited 1×
“of reasons leading to this phenomenon including the physical pain of finger pricking to obtain the blood sample, the damage to skin sensitivity at the fingertip, risk of infection, and economic aspects such as cost constraints of the health care cost carriers.(12,13) Moreover, invasive monitoring sensors do not provid…”
BackgroundInvasiveness as a Barrier to Self-Monitoring of Blood Glucose in Diabetes
Wagner, J., Malchoff, C., & Abbott, G. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.612 · Cited by 106 · cited 1×
“of reasons leading to this phenomenon including the physical pain of finger pricking to obtain the blood sample, the damage to skin sensitivity at the fingertip, risk of infection, and economic aspects such as cost constraints of the health care cost carriers.(12,13) Moreover, invasive monitoring sensors do not provid…”
BackgroundTowfigh, A., Romanova, M., Weinreb, J. E., Munjas, B. A., Suttorp, M. J., Zhou, A., & Shekelle, P. (2008) · PubMed · Cited by 101
Cobelli, C., Schiavon, M., Dalla Man, C., Basu, A., & Basu, R. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0112 · Cited by 83 · cited 1×
“20 Dynamic changes in the blood glucose content are known to be reflected in the tissue with a lag time induced by the shift of glucose from the vascular compartment to the interstitial fluid).(24) This lag time has been described to last from less than 10 minutes to more than 45 minutes based on the diabetes stage, a…”
BackgroundFrequency and motives of blood glucose self-monitoring in type 1 diabetes
Hansen, M. V., Pedersen‐Bjergaard, U., Heller, S. R., Wallace, T. M., Rasmussen, Å. K., Jørgensen, H. V., Pramming, S., & Thorsteinsson, B. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.022 · Cited by 78
Koschinsky, T., Jungheim, K., & Heinemann, L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322527030 · Cited by 64 · cited 1×
“This lag time has been described to last from less than 10 minutes to more than 45 minutes based on the diabetes stage, and in particular also related to the severity of secondary microcirculation disorders.(25-27) This fact explains why NI glucose monitoring methods are considered to be of limited efficacy in emergen…”
BackgroundDevice and method for noninvasive glucose assessment
Segman, Y. (. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818763457 · Cited by 55
Frequency of self-monitoring blood glucose and attainment of HbA1c target values
Elgart, J. F., González, L., Prestes, M., Rucci, E., & Gagliardino, J. J. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0745-9 · Cited by 51 · cited 1×
“One accepted measure is frequent glucose testing enabling targeted intervention and treatment intensification at the appropriate time-points.(5-9) However, glucose measurement is the most cumbersome aspect of diabetes treatment for many patients and many of them fail to adhere to the corresponding recommendations over…”
BackgroundKempf, K., Tankova, T., & Martin, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0213 · Cited by 40 · cited 4×
“1182 Journal of Diabetes Science and Technology 12(6)”
BackgroundInfluentialUnder-utilization of capillary glucose monitoring by type 2 diabetic patients
Brindisi, M., Hahn, J., Chiasson, J., & RABASA-LHORET, R. P. R. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.05.005 · Cited by 13
Glucose concentrations in blood and tissue - a pilot study on variable time lag
Chlup, R., Krejčí, J., O’Connell, M. T., Sebestova, B., Plička, R., Ježová, L., Brozova, T., Doubravová, B., Zálešáková, H., Ďurajková, E., et al. (2015) · Biomedical Papers · doi:10.5507/bp.2015.007 · Cited by 10 · cited 1×
“This lag time has been described to last from less than 10 minutes to more than 45 minutes based on the diabetes stage, and in particular also related to the severity of secondary microcirculation disorders.(25-27) This fact explains why NI glucose monitoring methods are considered to be of limited efficacy in emergen…”
Background
Research works printed but not linked: 1
- 23. Food and Drug Administration. FDA Self-monitoring blood glucose test systems for over-the-counter use. Guidance for industry and Food and Drug Administration staff; Available at: https://www.fda.gov/downloads/ucm380327.pdf. Accessed October 11, 2016. [Google Scholar]
Cited by
Villena Gonzales, W., Mobashsher, A., & Abbosh, A. (2019) · Sensors · doi:10.3390/s19040800 · Cited by 772
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Review of Non-Invasive Glucose Sensing Techniques: Optical, Electrical and Breath Acetone
Shokrekhodaei, M., & Quinones, S. (2020) · Sensors · doi:10.3390/s20051251 · Cited by 221
“In order to counter these effects, multi-technology and multi-sensors can be implemented and tailored to design a non-invasive sensor that is most sensitive to glucose molecules and independent of the many factors that contribute to false readings [65,147,166,167,211].”
BackgroundMethodSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
A Review of Non-Invasive Optical Systems for Continuous Blood Glucose Monitoring
Alsunaidi, B., Althobaiti, M., Tamal, M., Albaker, W. I., & Al-Naib, I. A. I. (2021) · Sensors · doi:10.3390/s21206820 · Cited by 127
Metadata
- Authors
- Pfützner, A., Strobl, S., Demircik, F., Redert, L., Pfützner, J., Pfützner, A. H., & Lier, A.
- Affiliations
- TH Bingen University of Applied Sciences (DE)
- Pfützner Science & Health Institute, Mainz, Germany
- Corresponding author
- Pfützner, Andreas
- ORCID
- Pfützner, Andreas
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2018-02-16
- Volume
- 12
- Issue
- 6
- Pages
- 1178-1183
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC6232728
- OpenAlex
- W2790254504
- Cited by
- 33
- References
- 28
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 4
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Keywords
- non-invasive glucose monitoring, type 1 diabetes, type 2 diabetes, blood glucose, mean absolute relative difference
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Eating, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Reference Standards, Blood Glucose Self-Monitoring, Postprandial Period, Young Adult, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.